BPC-157 Safety Information

BPC-157 (body protection compound-157) is a synthetic peptide derived from a sequence found in a protective protein in the stomach. In animal and laboratory studies, researchers have explored its role in tissue repair, blood-vessel formation, and gastrointestinal healing.

At Belle, BPC-157 is offered in compounded injectable form, prescribed when deemed clinically appropriate by a licensed healthcare provider. Please review the following important safety information before beginning treatment.

Regulatory Status

BPC-157 is not approved by the FDA for any indication. The FDA has reviewed BPC-157 as a bulk drug substance for use in compounding and has raised significant safety questions about it, citing limited safety data in humans. Its regulatory status is evolving, and availability through compounding pharmacies may change or be discontinued.

We would rather state that plainly than leave it in the small print. Your Belle clinician will explain what the current status means for you before anything is prescribed.

What Is BPC-157?

BPC-157 therapy is considered an elective wellness treatment. It has not been evaluated or approved by the FDA for recovery, tissue repair, gut health, athletic performance, or any other purpose. It is not intended to diagnose, treat, cure, or prevent any disease.

Most published research on BPC-157 is preclinical and conducted in animals. Well-controlled human studies are limited, and long-term safety in people has not been established. Promising findings in animal models do not automatically translate to proven results in humans.

Always consult your healthcare provider before beginning any injectable regimen, especially if you have pre-existing health conditions.

Who Should Not Use BPC-157

BPC-157 should not be used by individuals who:

Are allergic to BPC-157 or any ingredient in the formulation

Are pregnant, may become pregnant, or are breastfeeding

Have an active malignancy (cancer). BPC-157 has been studied for effects on blood-vessel formation, and the implications for tumor growth are not established

Are under 18 years of age

Have uncontrolled chronic illness without supervision from a licensed provider

Precautions and Warnings

Inform your provider if you have or have had:

Any history of cancer, or a family history that concerns you

Kidney or liver disease

Cardiovascular conditions

A bleeding disorder, or you take an anticoagulant

Gastrointestinal disease or a recent gastrointestinal procedure

An upcoming surgery, or a recent injury under the care of another provider

Tell your provider about all medications and supplements you take. If you compete in a tested sport, be aware that non-approved substances such as BPC-157 are generally prohibited in competition. Check with your sport's governing body before using any peptide therapy.

Common Side Effects

Because human data is limited, the side effect profile of BPC-157 is not well characterized. Reported effects are generally mild and local, and may include:

Injection site redness, swelling, or discomfort

Headache

Nausea or digestive upset

Dizziness or lightheadedness

Fatigue

If you experience any severe or prolonged symptoms, notify your provider immediately.

Serious Reactions (Rare)

In rare cases, patients may experience:

Hypersensitivity or allergic reaction

Worsening of pre-existing conditions

Unexpected effects not yet described in the literature, given the limited human safety record

Stop treatment and seek medical attention immediately if you experience trouble breathing, chest pain, or swelling of the face, lips, or throat.

Use and Administration

Use BPC-157 only as directed by your licensed provider.

Do not exceed the prescribed dosage or frequency.

BPC-157 is administered via subcutaneous injection, on the schedule your provider sets.

Rotate injection sites to reduce the chance of local reactions.

Do not use BPC-157 obtained from research chemical suppliers. Products labelled "for research use only" are not intended for human use and have no verified purity, sterility, or dose.

If you miss a dose, contact your provider for guidance before resuming.

Report any adverse effects or unexpected symptoms during treatment.

Storage and Disposal

Store BPC-157 as directed on the pharmacy label, typically refrigerated and protected from light. Do not use expired products. Dispose of needles and syringes in an approved sharps container. Keep out of reach of children.